Literature DB >> 9916

Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications.

M B Orringer, L Dabich, C J Zarafonetis, H Sloan.   

Abstract

Fifty-three patients with scleroderma were evaluated by history, barium swallow, and esophageal function tests. The most common esophageal symptoms were heartburn and dysphagia. Abnormal motility was seen radiologically in 43 patients, gastroesophageal reflux in only 9. Esophageal function tests demonstrated: (1) abnormal motility in 51 patients and lack of a distal esophageal high-pressure zone in 18; (2) moderate to severe gastroesophageal reflux in 38; and (3) abnormal acid-clearing ability in 50. Eleven patients, including 8 with peptic stricture, underwent the combined Collis-Belsey operation. Symptomatically, reflux was abolished in all and dysphagia in 10. Roentgenograms showed that regression of strictures was complete in 5 and partial in 3. Postoperative esophageal function tests in 9 patients demonstrated a competent distal esophageal valvular mechanism in 7. Gastroesophageal reflux, not impaired motility, is the major cause of esophageal symptoms in scleroderma. Its effecitve operative control is not contraindicated by systemic disease in these patients.

Entities:  

Mesh:

Year:  1976        PMID: 9916     DOI: 10.1016/s0003-4975(10)63972-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Intraesophageal pH monitoring during acid infusion in patients with systemic sclerosis.

Authors:  F Carola; P A Bianchi; G Basilisco
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 3.  Role and safety of fundoplication in esophageal disease and dysmotility syndromes.

Authors:  Charles T Bakhos; Roman V Petrov; Henry P Parkman; Zubair Malik; Abbas E Abbas
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

4.  Barrett's esophagus complicating scleroderma.

Authors:  F P Agha; L Dabich
Journal:  Gastrointest Radiol       Date:  1985

5.  Esophageal disease in progressive systemic sclerosis.

Authors:  Ellen C Ebert
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

6.  Gallbladder motility in systemic sclerosis.

Authors:  G Lock; M Zeuner; M Kammerl; B Lang; J Schölmerich; A Holstege
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 7.  Dysphagia in dermatologic disease.

Authors:  R Bübl; B Schön
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

8.  Transfer dysphagia in a patient with the rare combination of scleroderma and ankylosing spondylitis.

Authors:  P Witt; E Thomas
Journal:  J Natl Med Assoc       Date:  1987-09       Impact factor: 1.798

9.  Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Molgora; M Vanoli; P Bianchi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.